What Size Needle for IM Injections: Gauge and Length

The right needle for an intramuscular injection depends on the injection site, the patient’s body size, and their age, but for most adults receiving a deltoid injection, a 22- to 25-gauge needle that is 25 mm (1 inch) long is the standard starting point. That single recommendation, however, leaves out a lot. Body mass index, sex, and the specific muscle being targeted all shift what “right” means, and choosing poorly can lead to a medication landing in fat instead of muscle or, worse, penetrating too deep and hitting bone or nerve. The science behind needle selection has grown more precise in recent years, driven largely by ultrasound studies that measure the actual distance from skin surface to muscle in real patients.

What Gauge and Length Mean in Practice

Gauge refers to the diameter of the needle. The numbering is counterintuitive: a higher gauge number means a thinner needle. A 21-gauge needle is wider than a 25-gauge one. For IM injections, gauges between 20 and 25 are standard. Thinner needles (higher gauge) tend to cause less pain on entry, while wider ones allow thicker medications like oil-based suspensions to flow through more easily. A randomized trial comparing 30-gauge and 32-gauge needles for facial injections found that the thinner 32-gauge needle caused clinically significant pain in only 15% of patients, compared with 40% for the slightly wider 30-gauge needle.¹ Those gauges are finer than what you’d use for most IM medications, but the principle holds across the range: going narrower reduces discomfort at the skin surface.

Length is the more critical variable for IM success, because the needle must pass through skin and subcutaneous fat to reach muscle tissue. If it stops short, the medication ends up in fat, which can reduce how well the drug is absorbed and may cause local irritation or a sterile abscess.² If it goes too deep, it can hit bone, a bursa, or a nerve. Getting length right matters more than getting gauge perfect.

Deltoid Injections in Adults

The deltoid muscle in the upper arm is the most common site for vaccinations and many other IM medications. It is relatively thin compared to gluteal muscles, which means needle-length tolerances are tighter. An ultrasound study of older adults found that a 25 mm (1-inch) needle was sufficient to reach the deltoid muscle in all men regardless of BMI and in women with a BMI under 35. Women with a BMI above 35 needed a 32 mm needle to reliably reach muscle.³

A systematic review looking across multiple ultrasound studies confirmed the pattern: female sex, higher BMI, and greater body weight all increase the distance from the skin surface to the deltoid muscle.⁴ That same review found that some patients in every BMI category except underweight may need needles longer than 25 mm for a successful deltoid IM injection.⁵ In other words, a 25 mm needle works for most people but not all, and the ones it fails are disproportionately women with higher body weight.

For a typical adult with a BMI in the normal range, a 22- to 25-gauge, 25 mm needle is appropriate for deltoid injections. If you’re heavier, especially if you carry more weight in the upper arms, a 38 mm (1.5-inch) needle may be needed. Clinicians who have access to ultrasound can measure the actual skin-to-muscle distance, but in everyday practice, most providers estimate based on visible and palpable arm size combined with documented weight.

Gluteal Injections and the BMI Factor

The ventrogluteal and dorsogluteal sites in the hip and buttock are used for larger-volume IM injections and for medications that are irritating to smaller muscles. The tissue layers here are thicker, and the variation between individuals is dramatic. For ventrogluteal injections, research measuring skin-to-muscle depth found recommended needle lengths ranging from 20 mm in thin women up to 88 mm in obese women, and from 23 mm in thin men up to 82 mm in obese men.⁶ Those ranges are enormous, which is part of why gluteal injections are more prone to ending up in subcutaneous tissue if a standard-length needle is used on a larger patient.

A review focused specifically on obese patients concluded that needles longer than the standard 37 mm (about 1.5 inches) are recommended for all women, regardless of obesity status, when using any gluteal injection site.⁷ For men, the fat layer over the gluteal muscles tends to be thinner, so a 38 mm needle often reaches muscle even at higher BMIs. But for women, the subcutaneous fat layer in the gluteal region is substantially thicker on average, and 50 mm (2-inch) needles may be appropriate.

The dorsogluteal site, in the upper outer quadrant of the buttock, has fallen out of favor in many clinical guidelines because of the risk of hitting the sciatic nerve. That risk is real: the sciatic nerve is the most commonly injured nerve from IM injections, and the buttock is the most common site where these injuries occur.⁸ Children, older adults, and underweight patients are especially vulnerable because the nerve sits closer to the surface when muscle mass is low.⁹ When gluteal injections are necessary, the ventrogluteal site is generally preferred because it has a thicker muscle bed and the sciatic nerve is farther away.

Needle Selection for Children

Pediatric IM injections involve different muscles at different ages. Infants typically receive injections in the vastus lateralis, the large muscle on the outer thigh, because the deltoid is too small. Children over about three years old can receive deltoid injections depending on their muscle mass. The needle lengths used for children are shorter, but the margin for error is also smaller because the distance from skin to bone is much less.

A study using CT imaging to measure thigh tissue depth in children found that using the CDC’s recommended 1-inch (25 mm) needle for thigh injections in children aged one year and older resulted in overpenetration, where the needle went past the muscle toward bone, in about 11% of cases. Moving up to a 1.25-inch (32 mm) needle pushed the overpenetration rate to 39%.¹⁰ That finding suggests the standard recommendation may be too aggressive for some smaller children, and highlights why bunching up the thigh muscle before inserting the needle is an important technique in pediatric practice.

A Cochrane review of needle size for infant vaccination found that 25 mm needles for anterolateral thigh injections in infants aged two to six months reduced local reactions like redness and swelling compared to shorter 16 mm needles, while producing comparable immune responses.¹¹ The longer needle delivered the vaccine into muscle rather than fat, which resulted in less surface irritation. This is a good example of how going too short can cause problems even when the injection isn’t dangerous: the vaccine still works, but the patient ends up with more redness and a sore lump at the site.

Older Adults and Loss of Muscle Mass

Aging brings its own set of considerations. Older adults tend to lose muscle mass progressively, a process that accelerates after about age 65. An ultrasound study of Japanese adults over 50 found that the distance from the skin surface to the deltoid muscle fascia was shorter in adults 75 and older (about 7.5 mm) compared with those aged 50 to 64 (about 9.2 mm). More critically, the distance from skin to bone was also shorter in the oldest group, about 22.5 mm versus 25.4 mm in the 65-to-74 group. The study concluded that a 16 mm (five-eighths of an inch) needle was appropriate for average-sized older adults aged 50 and up, though larger individuals still needed longer needles.¹²

This creates a real tension in clinical practice. A 25 mm needle that is standard for most adults could overpenetrate in a thin older person, hitting the periosteum (the tissue layer over bone) or even the bursa beneath the deltoid. At the same time, if the older patient carries significant body fat, they might need a longer needle to reach the muscle through the fat layer. There is no one-size-fits-all rule for this population, and clinicians increasingly rely on visual and tactile assessment of the injection site rather than defaulting to a single standard needle.

When the Needle Goes Too Deep: Shoulder Injury After Vaccination

A complication that has received growing attention is shoulder injury related to vaccine administration, or SIRVA. This happens when a deltoid injection penetrates beyond the muscle into the subacromial space, the fluid-filled area beneath the bony tip of the shoulder. The result can be bursitis, frozen shoulder, or tendon damage that causes pain lasting weeks to months.

A 2025 study measured how far a standard-length needle would penetrate in 177 patients undergoing shoulder surgery. The researchers found that a needle length of only about 25 mm was enough to reach the subacromial space, and that overpenetration occurred in roughly half the cases tested. The study recommended that vaccination guidelines adopt a shorter 15 mm needle for most adults to keep the injection safely within the deltoid.¹³ That recommendation has not been widely adopted yet, and it sits in some tension with the evidence showing that many patients, especially women with higher BMI, actually need needles longer than 25 mm to reach the muscle at all. The conflicting data reflect a real dilemma: a needle that’s long enough to reach muscle in a heavier patient may be long enough to overshoot in a thinner one.

Prevention of SIRVA is as much about injection site placement as needle length. The injection should go into the thickest part of the deltoid, usually two to three finger-widths below the acromion (the bony point at the top of the shoulder). Injecting too high is the most common cause of SIRVA, regardless of needle length. Using an appropriate needle for the patient’s body size and placing the injection correctly together minimize the risk.¹⁴

Auto-Injectors and the One-Size Problem

Epinephrine auto-injectors like the EpiPen present a unique challenge because they come with a fixed needle length that cannot be adjusted for the patient’s body size. Since these devices are used in emergencies, often through clothing, the stakes are high. If the needle is too short, the epinephrine ends up in subcutaneous fat, where absorption is slower and less predictable. If the needle is too long in a small child, it could hit bone.

An ultrasound study found that some auto-injectors may not deliver epinephrine into muscle in a significant number of overweight and obese patients, particularly when injected through thick winter clothing. In children weighing under 15 kg, one auto-injector model had a 100% risk of subcutaneous injection when used through heavy layers. Balancing the risk of hitting bone in small patients against the risk of not reaching muscle in larger ones is a design problem that has no clean solution with a single fixed needle length.¹⁵

In women with confirmed food allergy, about 28% had a skin-to-muscle distance at the thigh that exceeded the EpiPen’s needle length, compared with none of the men. BMI was the strongest predictor of whether the needle would fall short.¹⁶ There is some reassurance, though: a pharmacokinetic study found that epinephrine delivered via EpiPen still reached the bloodstream faster and at higher peak levels than manual syringe injections with individually selected needle lengths, even in patients whose skin-to-muscle distance exceeded the device’s needle. The spring-loaded mechanism and force of delivery appear to compress the tissue enough to partially compensate.¹⁷ Still, if you carry an auto-injector and are aware that your body habitus may push the limits of its needle length, discussing the issue with your allergist is worthwhile. Injecting into the outer thigh with the device pressed firmly against bare skin (or as few clothing layers as possible) improves the odds of muscle delivery.

Technique Matters Beyond the Needle Itself

Choosing the right needle gets you partway there, but how the injection is performed also affects outcomes. The Z-track technique, where the skin is pulled to one side before inserting the needle and released afterward, was developed to prevent medication from leaking back along the needle track. A study of IM diclofenac injections found that the Z-track method reduced drug leakage at the skin surface from about 10 mm in diameter to about 7 mm, though it did not significantly reduce pain.¹⁸ For irritating medications or those that stain the skin, this matters. The technique is now recommended as standard practice for most IM injections, not just those with irritant drugs.

Aspiration, the practice of pulling back on the syringe plunger before injecting to check for blood, was once universal for IM injections. The rationale was to confirm the needle hadn’t entered a blood vessel. Most current guidelines, including the CDC’s immunization guidance, no longer recommend aspiration for deltoid and vastus lateralis injections because there are no large blood vessels at those sites and the practice adds pain and anxiety. Some agencies still recommend aspirating for dorsogluteal injections, where the gluteal artery is a consideration, but the trend is away from routine aspiration.

Quick-Reference Needle Sizes by Site and Patient

Keeping the caveats in mind, the following ranges reflect where the evidence clusters. These are not one-size-fits-all rules, and individual patient assessment should always inform the final choice.

Deltoid, normal-weight adult: 22–25 gauge, 25 mm (1 inch). Sufficient for most men and women with BMI under 35.
Deltoid, higher BMI: 22–25 gauge, 38 mm (1.5 inches). Women with BMI over 35 are most likely to need the longer needle.
Ventrogluteal, normal weight: 21–23 gauge, 38 mm (1.5 inches). Adequate for most average-sized adults.
Ventrogluteal, obese: 21–23 gauge, 50 mm (2 inches) or longer. Women typically need longer needles than men at similar BMIs.
Vastus lateralis, infant: 25 gauge, 25 mm (1 inch) for infants aged two to six months. Shorter 16 mm needles work but may deposit vaccine into fat, increasing local reactions.
Deltoid, thin older adult: 23–25 gauge, 16 mm (five-eighths inch) may be sufficient for average-sized elderly patients, with longer needles for those with more subcutaneous tissue.

Why Needle-Length Guidelines Lag Behind the Evidence

Most countries’ vaccination and injection guidelines still use a simplified framework: one needle length for adults, one for children, with perhaps a nod toward longer needles for larger patients. The evidence from ultrasound studies has been accumulating for over a decade showing that this approach leads to a substantial rate of injections that miss the muscle entirely, particularly in women. The mismatch is partly practical. Stocking multiple needle lengths adds complexity and cost to vaccination campaigns. Training healthcare workers to assess patients individually slows throughput, which matters when you’re vaccinating thousands of people per day during a pandemic. And for most medications, a subcutaneous injection that was intended to be intramuscular is not dangerous, just suboptimal.

But “suboptimal” is not the same as “fine.” Medications deposited in fat absorb more slowly and less predictably. Vaccines delivered subcutaneously may cause more local reactions. And for medications where the rate of absorption matters, like certain antipsychotics in long-acting injectable form or emergency medications, ending up in the wrong tissue layer can genuinely affect outcomes. The research suggests that if clinicians assessed injection-site depth even roughly, using arm circumference and BMI as proxies rather than ultrasound, they could improve accuracy substantially. Some newer clinical guidelines are beginning to incorporate BMI-based needle-length tables, but adoption has been slow and uneven across healthcare systems.